Cannabis Law Report

AUGUST 12, 2021

Phase IIb clinical trial of COMP360 psilocybin therapy for TRD close to completion. The contents of our website or these channels, or any other website that may be accessed from our website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933. Business highlights.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

DECEMBER 9, 2021

Forward-looking information is not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

JULY 14, 2021

ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. Forward-looking statements are statements that relate to future, not past, events. Karl Kottmeier” President. Investors are cautioned against attributing undue certainty to forward-looking statements.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

Cannabis Law Report

JULY 7, 2021

The power of the BioMAP Platform lies in the ability to compare a compound’s biological profile, or fingerprint, against a large reference database of profiles from approved drugs and tool compounds,” said Alison O’Mahony, Ph.D., This should remove the increased risk of infection, associated with all TNFi biological drugs used today.”.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Veriheal

JULY 12, 2021

For veterans, PTSD (sometimes referred to as ‘shell shock’ or ‘combat stress’) can severely impact their livelihood. The study revealed that cannabis reduced the severity of intrusive and returning thoughts of the traumatic event by 62%, reduced flashbacks by 51%, irritability by 67%, and anxiety by 57%.

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

NOVEMBER 15, 2021

References: Statement from then FDA Commissioner Scott Gottlieb, MD, and Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies. Investor Contact: Sanjay M.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

DECEMBER 7, 2021

While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. In conclusion, cannabidiol is associated with clinical improvement in Dravet syndrome. 1.69, 95% CI [1.20–2.36]) 1), 95%CI [??1.39–(??0.60)])

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

SEPTEMBER 8, 2021

EPN’s facility is capable of product development, manufacturing, and commercialization of cannabis consumer packaged goods in addition to the manufacture of products and formulations for use in clinical trials to a TGA and EU GMP standard. The risks described in such Annual Information Form are hereby incorporated by reference herein.

Access 97

Access Research and Development Medicine THC 97

The Cannigma

DECEMBER 12, 2022

Many psychedelics are also referred to as entheogens, which are substances that expand consciousness for religious or spiritual purposes. This decrease in DMN activity from psychedelics is sometimes referred to as “ego death,” and can be therapeutic to reset unhealthy thought patterns, almost like a brain reboot.

History 119

History Microdosing Research and Development Clinical Trials 119

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Adverse events reported for these participants were mild and included fatigue, diarrhea, and nausea. . References. The need for caution increases with higher doses.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

SEPTEMBER 24, 2019

We’re presuming both names “Epidyolex” & “Epidiolex” refer to exactly the same product and the former is the US product name and the latter the European brand name. Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. Forward-looking statements. Investor Relations.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

JUNE 29, 2022

While 233 participants might sound low, it is still the largest number of humans to participate in a psilocybin-based clinical trial. Adverse Events : This finding category refers to suicidal ideation and intentional self-injury, which were seen in all of the treatment groups.

Clinical Trials 103

Clinical Trials Blood Pressure Treatment Therapy 103

Cannabis Law Report

JULY 25, 2022

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. She was Founder and Executive Producer of the award-winning future-shaping events series, Creative Innovation Global. He has a B.Sc.

Medicine 52

Medicine Therapy Research and Development Business 52

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Adverse events reported for these participants were mild and included fatigue, diarrhea, and nausea. [7]. References. [1] 1] Stout, Stephen M., and Nina M.

CBD 52

CBD THC Conditions Medicine 52

Project CBD

FEBRUARY 28, 2023

Under section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act — in what some refer to as the “drug preclusion clause” 4 — any substance that is an active ingredient in an approved drug product, or that is being publicly investigated as such, is excluded from the definition of a legal dietary supplement ingredient.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JULY 28, 2021

We look forward to providing continued updates on our intellectual property, research, clinical, regulatory and manufacturing activities for PD-001; our novel oral formulation of cepharanthine, with the aim of working towards a first-in-human, proof-of-concept clinical trial under an FDA IND approval.” ” Next Steps.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

NOVEMBER 12, 2021

In the event that the Maximum LTV is exceeded, Brown Shipley can make a call on the Guarantors requiring them to place cash with Brown Shipley for the aggregate amount of the excess exposure over the Maximum LTV. OCT is conducting pre-clinical testing and development with pre-clinical trials scheduled for 2022.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

JANUARY 26, 2022

The Innovation Passport does not reduce the burden of demonstrating that a treatment may be safe and effective, but does provide research organizers with expert advice, patient input, and collaboration throughout the clinical trial design and development process through a product-specific Target Development Profile.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Puff Puff Post

SEPTEMBER 16, 2019

Clinical toolkits to help navigate patient assessment and follow-ups. Event details below: Date: Tuesday, September 17th 2019. Santé Cannabis is Québec’s leading specialized medical cannabis clinic and research centre, with clinics operating in Montreal, Quebec City, Sherbrooke and Pointe Claire.

Programs 108

Programs Research and Development Education Treatment 108

Puff Puff Post

SEPTEMBER 16, 2019

Clinical toolkits to help navigate patient assessment and follow-ups. Event details below: Date: Tuesday, September 17th 2019. Santé Cannabis is Québec’s leading specialized medical cannabis clinic and research centre, with clinics operating in Montreal, Quebec City, Sherbrooke and Pointe Claire.

Programs 40

Programs Research and Development Education Treatment 40

Cannabis Law Report

NOVEMBER 24, 2021

We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. While it may be legal in ACT it remains illegal under Commonwealth law and the legal situation remains fluid (Senate Community Affairs References Committee 2020 ). A recent study by Lintzeris et al.

Research and Development 52

Research and Development Medicine Access Media 52

SMPL

MAY 26, 2020

We were talking about, ‘What can we do with this?’ ” recalled Samantha Miller, who hosted the event at her split-level house, wedged between redwoods and a creek below. Mr. Gardner was elated, and began referring to his efforts as “Project CBD” alongside other supporters, including Mr. Lee, the writer.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Thus far, however, there have been no FDA -sanctioned clinical trials to ascertain the efficacy of whole plant, CBD -rich cannabis oil for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Thus far, however, there have been no FDA -sanctioned clinical trials to ascertain the efficacy of whole plant, CBD -rich cannabis oil for traumatic brain injury.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

NORML

SEPTEMBER 20, 2019

But at the Vegas event, she brought good news: She announced that other universities would host her research, and she recently applied for a third-party cultivation license from the DEA, the only federal agency that can legally provide cannabis for clinical study in the US.

DEA 230

DEA Research and Development Clinical Trials Patients 230